利索-全球专利检索

  1. 登录
  2. 注册
发明公开
CN110507657A 一种抗肺腺癌药物组合物及By-1作为一代抗肺腺癌药物增效剂的应用 有权

一种抗肺腺癌药物组合物及By-1作为一代抗肺腺癌药物增效剂的应用
摘要：
本发明公开了一种抗肺腺癌药物组合物及By-1作为一代抗肺腺癌药物增效剂的应用，By-1与吉非替尼联合用药对于非小细胞肺腺癌的治疗产生了显著的协同增效，By-1能够作为吉非替尼的增效剂，与吉非替尼联合，能够显著增强吉非替尼对于非小细胞肺腺癌的治疗效果。
摘要（英）：

The invention discloses a medical composition for resisting lung adenocarcinoma, and an application of By-1 as a first-generation medical synergist for resisting lung adenocarcinoma. The By-1 and gefitinib are in united medication to produce significant synergistic effects on treatment of non small cell lung adenocarcinoma, and the By-1 can be used as a synergist of the gefitinib and can be unitedwith the gefitinib, so that the treatment effects of the gefitinib on the non small cell lung adenocarcinoma can be significantly strengthened.

公开/授权文献
0/0